OncoCyte Tax Provision from 2010 to 2025

OCX Stock  USD 3.40  0.10  3.03%   
OncoCyte Corp Tax Provision yearly trend continues to be fairly stable with very little volatility. Tax Provision is likely to outpace its year average in 2025. Tax Provision is the amount set aside by OncoCyte Corp to cover any estimated taxes for the current period. It reflects OncoCyte Corp's expected tax liabilities. View All Fundamentals
 
Tax Provision  
First Reported
2013-12-31
Previous Quarter
922 K
Current Value
0.0
Quarterly Volatility
9.1 M
 
Yuan Drop
 
Covid
Check OncoCyte Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OncoCyte Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 56.8 K or Selling General Administrative of 11.2 M, as well as many indicators such as Price To Sales Ratio of 13.9, Dividend Yield of 0.0015 or PTB Ratio of 0.64. OncoCyte financial statements analysis is a perfect complement when working with OncoCyte Corp Valuation or Volatility modules.
  
Check out the analysis of OncoCyte Corp Correlation against competitors.
For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.

Latest OncoCyte Corp's Tax Provision Growth Pattern

Below is the plot of the Tax Provision of OncoCyte Corp over the last few years. It is the amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities. OncoCyte Corp's Tax Provision historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OncoCyte Corp's overall financial position and show how it may be relating to other accounts over time.
Tax Provision10 Years Trend
Very volatile
   Tax Provision   
       Timeline  

OncoCyte Tax Provision Regression Statistics

Arithmetic Mean(1,414,520)
Geometric Mean764,892
Coefficient Of Variation(153.91)
Mean Deviation980,810
Median(1,254,000)
Standard Deviation2,177,076
Sample Variance4.7T
Range9.4M
R-Value0.03
Mean Square Error5.1T
R-Squared0.0009
Significance0.91
Slope13,662
Total Sum of Squares71.1T

OncoCyte Tax Provision History

2025117.1 K
2024111.5 K
202297 K
2021-9.3 M

About OncoCyte Corp Financial Statements

OncoCyte Corp investors use historical fundamental indicators, such as OncoCyte Corp's Tax Provision, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OncoCyte Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Tax Provision111.5 K117.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OncoCyte Stock Analysis

When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.